1 documents found
Information × Registration Number 0125U002130, R & D request Title A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study to evaluate the efficacy and safety of pimodivir in combination with standard tolerance in adolescent, adult and elderly patients with influenza A infection who have not been hospitalised and are at risk of complications Head Dubynska Halyna M., д.мед.н. Registration Date 11-04-2025 Organization Poltava State Medical University popup.description1 To evaluate the efficacy and safety of pimodivir in combination with standard tolerance in adolescent, adult and elderly patients with influenza A infection who were not hospitalised and are at risk of complications popup.nrat_date 2025-04-11 Close
search.res_rk
A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study to evaluate the efficacy and safety of pimodivir in combination with standard tolerance in adolescent, adult and elderly patients with influenza A infection who have not been hospitalised and are at risk of complications
Head: Dubynska Halyna M.. A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study to evaluate the efficacy and safety of pimodivir in combination with standard tolerance in adolescent, adult and elderly patients with influenza A infection who have not been hospitalised and are at risk of complications. Poltava State Medical University. № 0125U002130
1 documents found

Updated: 2026-03-28


Роздрукувати цю сторінку